Stay updated with breaking news from Flovent Diskus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Three of the four major inhaler manufacturers have announced plans to cap patient copays for all their inhalers at $35 a month in recent weeks, in addition to lowering the list prices of some of those products.
Three of the four major inhaler manufacturers have announced plans to cap patient copays for all their inhalers at $35 a month in recent weeks, in addition to lowering the list prices of some of those products.
Three inhaler manufacturers will cap patient copays for their inhalers at $35 a month and lower the list prices of some of those products.
Three of the largest inhaler manufacturers have already said they'd be capping inhaler co-pays at $35 monthly.
:max_bytes(150000):strip_icc()/GettyImages-482145883-7a774c0e331d4cc8b16900c4536a2df3.jpg)
Flovent, a common asthma medication, is no longer available in the U.S. Find out why that is, how you might be impacted, and what you can do.